Objective Biotechnology的动态

Here’s my just-released podcast interview with Jordan Harbinger about my new book and about what the intersecting AI, genetics, and biotechnology revolutions mean for the future of life. #AI #technology #biotechnology

I recently had the profound pleasure of sitting down with Dr. Neal Baer, luminary in both the medical and entertainment fields, on the latest episode of the FUTUREPROOF. Podcast. Neal, whose groundbreaking work spans from 'ER' (and being the showrunner of Law & Order: SVU, which I *LOVE*) to addressing global health crises, dives deep into the ethical, societal, and scientific ramifications of CRISPR technology. In our conversation, we cover the incredible potential of gene editing to cure diseases and the daunting risks that accompany its power. From editing the human genome to the specter of designer pathogens, Neal provides an authoritative yet accessible exploration of CRISPR’s dual-edged impact. ?? Tune in to discover: - The critical importance of public discourse in shaping the future of gene editing. - Strategies to mitigate the misuse of this formidable technology. - The balance of innovation against ethical considerations in the pursuit of scientific advancement. As we stand at the crossroads of monumental scientific capabilities, Neal’s insights are more crucial than ever. Join us for a compelling dialogue on the future of medicine, ethics, and humanity itself. ?? Listen now https://lnkd.in/d5zw_NgN ?? What are your thoughts on the balance between innovation and ethical responsibility in science? How do you see CRISPR shaping the future of healthcare? #FUTUREPROOF #CRISPR #GeneEditing #EthicsInScience #HealthcareInnovation

Our CEO Peyman Salehian (Ph.D.), was recently featured on a podcast hosted by Bakytzhan Akhmetov, PhD ?? In the episode, Peyman discusses our groundbreaking enzyme technology, how we've built the world's deepest enzyme data library, and our recent Series A funding round. Listen and learn how we're biotransforming chemistry ?? #Allozymes #Biotechnology #Enzymes

Using AI to combat hunger ?? As a scientist and biotech enthusiast, Bill shares his insights on how AI is accelerating agricultural innovations to address global challenges like hunger and climate change. ???? From empowering smallholder farmers to fostering innovation within Bayer, this episode is a must-listen for anyone interested in the intersection of science, technology, and sustainability. ?? Listen to the full episode here ttps://https://lnkd.in/e3CUp7vS and join the conversation on how we can achieve ‘Health for All, Hunger for None’. #Agriculture #Innovation #Sustainability #ArtificialIntelligence #Podcast

Designing or identifying small molecules to target proteins of interest is just not a bottleneck in generating improved medicines. I’m a little disappointed that DeepMind’s CEO sees this as the next big thing to follow AlphaFold. I feel like there’s an irresistible slide from “protein structures!” to “drugs to target protein structure!” This logic completely disconnected from how new medicines are made. Will your AI generated compound insure success in a clinical trial? that’s the actual bottleneck. https://lnkd.in/eF3AnkpK

#VirtualYou: How Building Your Digital Twin Will Revolutionize Medicine and Change Your Life https://lnkd.in/ess65dNf Honour and pleasure to talk about my Princeton University Press book, written with Peter Coveney , with brilliant Angela Saini for the AAAS Science podcast!!!

Biotech + Blue Ocean Strategy = Space medicine Came across a very exciting new biotech company - LinkGevity - which is essentially applying blue ocean strategy to biotech drug and target discovery. Instead of focusing on downstream pathways implicated in specific diseases, they try to identify upstream dysregulations that lead to multiple diseases and thereby break outside of the clutter of disease specific discovery programs. First proof of concept - necrosis* pathway: cellular stress that leads to organ damage (e.g. Acute Kidney Injury). Example of application: preserving kidney function in extended duration space travel (apparently it's not only cost and technology that limits our ability to go to Mars, but also human physical limitations - our kidney's won't last the trip). * Necrosis is typically viewed as a damaging, uncontrolled form of cell death that leads to inflammation and tissue injury, and it's generally less beneficial than other types of cell death, like apoptosis. While necrosis has some biological utility, its benefits are context-specific, typically aiding in emergency situations like infection or acute injury. In chronic conditions, persistent or excessive necrosis contributes to inflammation and tissue damage, making it a target for therapeutic intervention in age-related and inflammatory diseases. Learn more about LinkGevity from this podcast by Labiotech.eu:

It continues to be a pleasure and privilege to speak with so many expectional scientists. Get your fix for relevance to glycobiology, Imaging, and even pharma in this episode with Christopher Taron. #omgomx #bruker #podcast

This episode of the Innovation Origins podcast offers in-depth insights into how technological innovations and strategic collaborations are contributing to a more sustainable future.

Do you want to learn about #NAMs & the #3Rs? Are you a student or a scientist looking for resources? ???? Get started with your topic of interest, listen to the StudentCast 3Rs podcast, & test your knowledge in the quiz. #AnimalWelfare #HumaneEducation https://lnkd.in/genhdicd